I really don't think you need anything more to explain the sector moves than the Trump statements plus the momentum traders.
The threat of drawing Trump's attention will certainly concentrate the minds of the industry - so expect high profile pricing increases to be a thing of the past. Trump would like nothing more than to have some company rescind a price increase after he tweeted about it.
REGN to date the best behaved by far on pricing of a high priced drug (Eylea).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.